Viromed Medical AG (Q11) — Capital Reinvestment Ratio

Latest as of December 2024: 4.82x

Viromed Medical AG (Q11) has a Capital Reinvestment Ratio of 4.82x as of December 2024, meaning it reinvests 5% of its operating cash flow (€7.45 Million) in capital expenditures (€35.91 Million). Check Q11 tangible net assets ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

4.82x

Capex / Operating Cash Flow

Operating Cash Flow

€7.45 Million

EUR

Capital Expenditures

€35.91 Million

EUR

Data as of

Dec 2024

Most recent filing

Annual Capital Reinvestment Ratio for Viromed Medical AG (None–None)

Year-by-year Capital Reinvestment Ratio for Viromed Medical AG from None to None. See how much free cash does Viromed Medical AG generate to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (EUR)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow